Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform.
Saved in:
| Title: | Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform. |
|---|---|
| Authors: | Volkman, Hannah R.1 (AUTHOR) hannah.volkman@pfizer.com, de Munter, Leonie2 (AUTHOR), Nguyen, Jennifer L.1 (AUTHOR), Tran, Thao M. P.2 (AUTHOR), Mitratza, Marianna2 (AUTHOR), Marques, Cátia1 (AUTHOR), Choi, Laura1 (AUTHOR), Valluri, Srinivas1 (AUTHOR), Yang, Jingyan1 (AUTHOR), Antón, Andrés3 (AUTHOR), Casas, Irma4 (AUTHOR), Conde-Sousa, Eduardo2 (AUTHOR), Drikite, Laura2 (AUTHOR), Grüner, Beate5 (AUTHOR), Icardi, Giancarlo6 (AUTHOR), ten Kate, Gerrit Luit7 (AUTHOR), Martin, Charlotte8 (AUTHOR), Mira-Iglesias, Ainara9,10 (AUTHOR), Orrico-Sánchez, Alejandro9,10,11 (AUTHOR), Otero-Romero, Susana12,13 (AUTHOR) |
| Source: | PLoS ONE. 2/11/2026, Vol. 21 Issue 2, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0342382 |
